We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Verona Pharma Plc | LSE:VRP | London | Ordinary Share | GB00BYW2KH80 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 55.00 | 45.00 | 65.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
The notification of dealing form can be found below.
For further information, please contact:
Verona Pharma plc | Tel: +44 (0)20 3283 4200 |
Jan-Anders Karlsson, Chief Executive Officer | info@veronapharma.com |
N+1 Singer (Nominated Adviser and UK Broker) | Tel: +44 (0)20 7496 3000 |
Aubrey Powell / James White | |
FTI Consulting (UK Media and Investor enquiries) | Tel: +44 (0)20 3727 1000 |
Simon Conway / Natalie Garland-Collins | veronapharma@fticonsulting.com |
ICR, Inc. (US Media and Investor enquiries) | |
Darcie Robinson | Tel: +1 203-682-8379Darcie.Robinson@icrinc.com |
Stephanie Carrington | Tel. +1 646-277-1282Stephanie.Carrington@icrinc.com |
1 | Details of the person discharging managerial responsibilities/person closely associated | ||
a) | Name | David Ebsworth | |
2 | Reason for the notification | ||
a) | Position/status | Non-Executive Chairman | |
b) | Initial notification/Amendment | Initial notification | |
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
a) | Name | Verona Pharma plc | |
b) | LEI | 213800EVI6O6J3TIAL06 | |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
a) | Description of the financial instrument, type of instrument | Ordinary Shares of 5 pence each | |
Identification code | GB00BYW2KH80 | ||
b) | Nature of the transaction | David Ebsworth purchased 8,130 Ordinary Shares | |
c) | Price(s) and volume(s) | Price(s) | Volume(s) |
122.5 pence per Ordinary Share | 8,130 Ordinary Shares | ||
d) | Aggregated information | N/A | |
- Aggregated volume | |||
- Price | |||
e) | Date of the transaction | 17 August 2017 | |
f) | Place of the transaction | London Stock Exchange, AIM |
1 Year Verona Pharma Chart |
1 Month Verona Pharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions